title: Obesity modifies expression profiles of metabolic markers in superficial and deep subcutaneous abdominal adipose tissue depots.
abstract: While visceral adipose tissue (VAT) associates to obesity, there is debate for subcutaneous adipose tissue (SAT). One explanation may be SAT subcompartments, superficial-SAT (sSAT) and deep-SAT (dSAT), recently recognized as independent depots. Our aim was to establish roles for sSAT/dSAT with obesity by examining the expression of proteins key to adipocyte metabolism. Paired biopsies from sSAT and dSAT of 10 normal-weight (BMI 21.8 ± 0.8 kg/m(2)) and 11 obese subjects (BMI 44 ± 2.1 kg/m(2)) were analyzed for differences in insulin sensitivity using adiponectin, GLUT4 and resistin, glucocorticoid metabolism by 11βHSD1 and alterations of the adipokines leptin and TNFα. Between lean and obese subjects, sSAT and dSAT changes for GLUT4, resistin and TNFα were equivalent. Resistin and TNFα increased in both obese SAT sub-compartments; 33-fold (sSAT; P < 0.006) and 18.5-fold (dSAT; P < 0.003) higher resistin, with undetectable in leans to significant TNFα levels in obese. In contrast, GLUT4 showed 5.5-fold (sSAT; P < 0.03) and 7-fold (dSAT; P < 0.03) lower levels in obese, correlating to BMI (r = -0.6423, P = 0.007) and HOMA-IR (r = -0.5882, P = 0.017). Exclusive sSAT-specific differences were observed for adiponectin, leptin, and 11βHSD1. Both sSAT 11βHSD1 and leptin increased in obese, with 11βHSD1 2.5-fold (P = 0.052) and leptin 3.3-fold (P < 0.008) higher, with 11βHSD1 correlating to HOMA-IR (r = 0.5203, P = 0.0323) and leptin to BMI (r = 0.5810, P = 0.01). In contrast, obese had 7-fold (P < 0.02) lower sSAT adiponectin, correlating to BMI (r = -0.5178, P = 0.027) and HOMA-IR (r = -0.4570, P = 0.049). Overall, sSAT and dSAT are distinct abdominal adipose tissue depots with independent metabolic functions. Between the two, sSAT shows clear independent effects that associate to obesity and its metabolic complications.
authors.affiliation: Laboratory of Molecular Biology, I.R.C.C.S. Istituto Auxologico Italiano, Piancavallo, VB, Italy, gillian.walker@med.unipmn.it.
authors.forename: Gillian E
authors.initials: GE
authors.lastname: Walker
authors.forename: Paolo
authors.initials: P
authors.lastname: Marzullo
authors.forename: Flavia
authors.initials: F
authors.lastname: Prodam
authors.forename: Gianni
authors.initials: G
authors.lastname: Bona
authors.forename: Anna Maria
authors.initials: AM
authors.lastname: Di Blasio
mesh_terms: D017667:Adipocytes / Q000378:metabolism / Q000502:physiology; D054392:Adipokines / Q000378:metabolism; D000328:Adult; D015415:Biomarkers / Q000378:metabolism*; D001706:Biopsy; D005260:Female; D005938:Glucocorticoids / Q000378:metabolism; D005947:Glucose / Q000378:metabolism; D006801:Humans; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000378:metabolism*; D012313:RNA / Q000096:biosynthesis / Q000302:isolation & purification; D060888:Real-Time Polymerase Chain Reaction; D050507:Subcutaneous Fat, Abdominal / Q000378:metabolism*
chemical_list: D054392:Adipokines; D015415:Biomarkers; D005938:Glucocorticoids; D012313:RNA; D005947:Glucose
references.citation: Diabetes. 2005 Apr;54(4):1023-31
references.pmid: 15793240
references.citation: Endocrine. 2012 Jun;41(3):374-83
references.pmid: 22434412
references.citation: J Clin Endocrinol Metab. 2008 Nov;93(11):4276-81
references.pmid: 18713823
references.citation: Mol Aspects Med. 2013 Feb;34(1):1-11
references.pmid: 23068073
references.citation: Diabetes. 2002 Apr;51(4):1005-15
references.pmid: 11916919
references.citation: J Atheroscler Thromb. 2011;18(8):629-39
references.pmid: 21737960
references.citation: Am J Physiol Endocrinol Metab. 2000 May;278(5):E941-8
references.pmid: 10780952
references.citation: Eur J Clin Nutr. 1992 Dec;46(12):903-6
references.pmid: 1483420
references.citation: Diabetologia. 1997 May;40(5):590-8
references.pmid: 9165229
references.citation: Am J Clin Nutr. 1956 Jan-Feb;4(1):20-34
references.pmid: 13282851
references.citation: Am J Physiol Endocrinol Metab. 2003 Nov;285(5):E1072-80
references.pmid: 12876073
references.citation: Obesity (Silver Spring). 2007 Aug;15(8):1933-43
references.pmid: 17712110
references.citation: J Proteomics. 2011 Jun 10;74(7):1068-79
references.pmid: 21439414
references.citation: Biochem Biophys Res Commun. 2003 Oct 24;310(3):927-35
references.pmid: 14550293
references.citation: J Clin Endocrinol Metab. 2008 Jun;93(6):2122-8
references.pmid: 18397988
references.citation: Diabetes. 2011 Apr;60(4):1158-67
references.pmid: 21350084
references.citation: Diabetes. 2004 Apr;53(4):931-8
references.pmid: 15047607
references.citation: Endocr Rev. 2000 Dec;21(6):697-738
references.pmid: 11133069
references.citation: Am J Clin Nutr. 2012 Oct;96(4):714-26
references.pmid: 22932278
references.citation: Am J Physiol Endocrinol Metab. 2005 Oct;289(4):E551-61
references.pmid: 15928024
references.citation: Diabetes Res Clin Pract. 2008 Feb;79(2):214-9
references.pmid: 17935818
references.citation: J Clin Endocrinol Metab. 2011 Nov;96(11):E1782-8
references.pmid: 21865369
references.citation: Eur J Endocrinol. 1999 Oct;141(4):436-42
references.pmid: 10526261
references.citation: Trends Endocrinol Metab. 2002 Apr;13(3):94-6
references.pmid: 11893517
references.citation: J Obes. 2013;2013:393192
references.pmid: 23653857
references.citation: Nature. 2001 Jan 18;409(6818):307-12
references.pmid: 11201732